Indeed, high phosphorylated SRSF6 levels in neuronal cells of HD patients favored a specific MAP2 isoform and its localization at the stroma instead at the dendrites, with an alteration of the cytoskeleton with dendrite atrophy. Here, MAP2 is linked to Huntington disease.